Chimeric antigen receptors can redirect and activate T cells toward specific cancers because the receptors are composed of a single-chain Fv antibody against a target cancer antigen in the extracellular domain and a co-stimulatory/CD3ζ chimeric signaling region in the cytoplasmic domain13. Here, CD247 is linked to cancer.